Kathryn McCollister1, Xuan Yang2, Bisma Sayed3, Michael T French4, Jared A Leff5, Bruce R Schackman6. 1. Department of Public Health Sciences, University of Miami Miller School of Medicine, Soffer Clinical Research Center, Suite 1019, 1120 NW 14th Street, Miami, FL 33136, USA. Electronic address: kmccolli@miami.edu. 2. Department of Public Health Sciences, University of Miami Miller School of Medicine, Soffer Clinical Research Center, Suite 1019, 1120 NW 14th Street, Miami, FL 33136, USA. Electronic address: xxy100@med.miami.edu. 3. Department of Sociology and Health Economics Research Group, University of Miami, 5665 Ponce de Leon Boulevard, Flipse Building, Room 122, P.O. Box 248251, Coral Gables, FL 33124, USA. Electronic address: bsayed@mail.as.miami.edu. 4. Department of Health Sector Management and Policy, Department of Sociology, University of Miami, School of Business Administration, P.O. Box 248027, Coral Gables, FL 33124, USA. Electronic address: mfrench@miami.edu. 5. Department of Healthcare Policy & Research, Weill Cornell Medical College, 425 E 61st Street, Suite 301, New York, NY 10065, USA. Electronic address: jal2033@med.cornell.edu. 6. Department of Healthcare Policy & Research, Weill Cornell Medical College, 425 E 61st Street, Suite 301, New York, NY 10065, USA. Electronic address: brs2006@med.cornell.edu.
Abstract
AIMS: Estimating the economic consequences of substance use disorders (SUDs) is important for evaluating existing programs and new interventions. Policy makers in particular must weigh program effectiveness with scalability and sustainability considerations in deciding which programs to fund with limited resources. This study provides a comprehensive list of monetary conversion factors for a broad range of consequences, services, and outcomes, which can be used in economic evaluations of SUD interventions (primarily in the United States), including common co-occurring conditions such as HCV and HIV. METHODS: Economic measures were selected from standardized clinical assessment instruments that are used in randomized clinical trials and other research studies (e.g., quasi-experimental community-based projects) to evaluate the impact of SUD interventions. National datasets were also reviewed for additional SUD-related consequences, services, and outcomes. Monetary conversion factors were identified through a comprehensive literature review of published articles as well as targeted searches of other sources such as government reports. RESULTS: Eight service/consequence/outcome domains were identified containing more than sixty monetizable measures of medical and behavioral health services, laboratory services, SUD treatment, social services, productivity outcomes, disability outcomes, criminal activity and criminal justice services, and infectious diseases consequences. Unit-specific monetary conversion factors are reported, along with upper and lower bound estimates, whenever possible. CONCLUSIONS: Having an updated and standardized source of monetary conversion factors will facilitate and improve future economic evaluations of interventions targeting SUDs and other risky behaviors. This exercise should be repeated periodically as new sources of data become available to maintain the timeliness, comprehensiveness, and quality of these estimates.
AIMS: Estimating the economic consequences of substance use disorders (SUDs) is important for evaluating existing programs and new interventions. Policy makers in particular must weigh program effectiveness with scalability and sustainability considerations in deciding which programs to fund with limited resources. This study provides a comprehensive list of monetary conversion factors for a broad range of consequences, services, and outcomes, which can be used in economic evaluations of SUD interventions (primarily in the United States), including common co-occurring conditions such as HCV and HIV. METHODS: Economic measures were selected from standardized clinical assessment instruments that are used in randomized clinical trials and other research studies (e.g., quasi-experimental community-based projects) to evaluate the impact of SUD interventions. National datasets were also reviewed for additional SUD-related consequences, services, and outcomes. Monetary conversion factors were identified through a comprehensive literature review of published articles as well as targeted searches of other sources such as government reports. RESULTS: Eight service/consequence/outcome domains were identified containing more than sixty monetizable measures of medical and behavioral health services, laboratory services, SUD treatment, social services, productivity outcomes, disability outcomes, criminal activity and criminal justice services, and infectious diseases consequences. Unit-specific monetary conversion factors are reported, along with upper and lower bound estimates, whenever possible. CONCLUSIONS: Having an updated and standardized source of monetary conversion factors will facilitate and improve future economic evaluations of interventions targeting SUDs and other risky behaviors. This exercise should be repeated periodically as new sources of data become available to maintain the timeliness, comprehensiveness, and quality of these estimates.
Authors: Pierre K Alexandre; Isabelle C Beulaygue; Michael T French; Kathryn E McCollister; Ioana Popovici; Bisma A Sayed Journal: Eval Rev Date: 2012-06-17
Authors: Susan L Ettner; David Huang; Elizabeth Evans; Danielle Rose Ash; Mary Hardy; Mickel Jourabchi; Yih-Ing Hser Journal: Health Serv Res Date: 2006-02 Impact factor: 3.402
Authors: Don Husereau; Michael Drummond; Stavros Petrou; Chris Carswell; David Moher; Dan Greenberg; Federico Augustovski; Andrew H Briggs; Josephine Mauskopf; Elizabeth Loder Journal: Value Health Date: 2013 Mar-Apr Impact factor: 5.725
Authors: Bruce R Schackman; John A Fleishman; Amanda E Su; Bethany K Berkowitz; Richard D Moore; Rochelle P Walensky; Jessica E Becker; Cindy Voss; A David Paltiel; Milton C Weinstein; Kenneth A Freedberg; Kelly A Gebo; Elena Losina Journal: Med Care Date: 2015-04 Impact factor: 2.983
Authors: Kwame Owusu-Edusei; Harrell W Chesson; Thomas L Gift; Guoyu Tao; Reena Mahajan; Marie Cheryl Bañez Ocfemia; Charlotte K Kent Journal: Sex Transm Dis Date: 2013-03 Impact factor: 2.830
Authors: Carolina Barbosa; Brendan Wedehase; Laura Dunlap; Shannon Gwin Mitchell; Kristi Dusek; Robert P Schwartz; Jan Gryzcynski; Arethusa S Kirk; Marla Oros; Colleen Hosler; Kevin E O'Grady; Barry S Brown Journal: J Stud Alcohol Drugs Date: 2018-05 Impact factor: 2.582
Authors: Hilary L Surratt; Janet K Otachi; Timothy Williams; Jennifer Gulley; A Scott Lockard; Rebecca Rains Journal: J Rural Health Date: 2019-08-15 Impact factor: 4.333
Authors: Laura J Dunlap; Stephen Orme; Gary A Zarkin; David R Holtgrave; Catherine Maulsby; Andrew M Rodewald; August F Holtyn; Kenneth Silverman Journal: AIDS Behav Date: 2021-08-26
Authors: Stephen Orme; Gary A Zarkin; Laura J Dunlap; Courtney D Nordeck; Robert P Schwartz; Shannon G Mitchell; Christopher Welsh; Kevin E O'Grady; Jan Gryczynski Journal: Med Care Date: 2022-06-10 Impact factor: 3.178
Authors: Sarah Gutkind; Bruce R Schackman; Jake R Morgan; Jared A Leff; Linda Agyemang; Sean M Murphy; Matthew J Akiyama; Brianna L Norton; Alain H Litwin; Benjamin P Linas Journal: Clin Infect Dis Date: 2020-03-17 Impact factor: 20.999
Authors: Elizabeth A Evans; Thomas J Stopka; Ekaterina Pivovarova; Sean M Murphy; Faye S Taxman; Warren J Ferguson; Dana Bernson; Claudia Santelices; Kathryn E McCollister; Randall Hoskinson; Thomas Lincoln; Peter D Friedmann Journal: J Subst Abuse Treat Date: 2021-01-08